Trademark Overview
On Monday, December 9, 2024, a trademark application was filed for EXTASHIELD with the United States Patent and Trademark Office. The USPTO has given the EXTASHIELD trademark a serial number of 98892137. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, December 9, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The EXTASHIELD trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious disease; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders